Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AndroGel Trial Ends In Defense Verdict In Illinois State Court September 12, 2017 Irvin Jackson Add Your Comments As thousands of lawsuits over heart attacks and other injuries linked to testosterone treatments continue to move forward through the U.S. court system, early trials have resulted in split verdicts, with a federal jury awarding $150 million in damages in July, but a separate Illinois state court jury returning a defense verdict last week. However, additional cases are set to go before other juries in the coming weeks, with another federal “bellwether” trial sent to begin next week. While testosterone replacement therapy was originally intended to serve as a niche treatment for men suffering from testosterone deficiencies caused by a medical condition, such as hypogonadism, amid aggressive marketing of drugs like Androgel, Testim, Axiron and others, the industry grew to generate more than $2 billion in annual sales several years ago. There are currently more than 6,500 Androgel lawsuits, Testim lawsuits, Axiron lawsuits and other product liability claims pending nationwide against the markers of various testosterone treatments, alleging that inadequate warnings were provided to users and the medical community about the risk of heart attacks, strokes, blood clots and other health problems. Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In July, the first federal “bellwether” trial resulted in a massive punitive damage award against the makers of Androgel, in a case filed by a man who claimed that he suffered a heart attack following use of the drug. While the jury chose to punish the drug maker for recklessly disregarding the safety of the plaintiff and other consumers, no compensatory damages were awarded, raising questions about whether the punitive damage award will stand and whether a re-trial will be necessary. Last week, a second trial concluded in Cook County, Illinois, involving a lawsuit filed by James Couch, who claimed that he suffered a heart attack two weeks after he began Androgel treatment. The jury found in favor of the drug maker, AbbVie, finding that the it was not liable for Couch’s injuries. The defense verdict comes as another federal trial is slated to begin jury selections on September 18, involving a lawsuit filed by Jeffrey Konrad, also involving a heart attack allegedly caused by the testosterone gel. This will be the second attempt to place Konrad’s claims before a jury, after an earlier trial in June ended in a mistrial, when one of the involved attorneys suddenly became ill and was unable to continue. Konrad indicates that he was prescribed AndroGel by his family physician in May 2010, and approximately two months later he suffered a heart attack. The lawsuit will involve allegations that AndroGel is unreasonably dangerous, and that AbbVie misrepresented the safety of the testosterone treatment, withholding information about the risk of heart attacks and other injuries. The case is part of a series of “bellwether” trials scheduled in the federal court system, which are each designed to help gauge how juries will respond to certain evidence and testimony that is likely to be similar to what will be repeated throughout other cases. Another federal Androgel trial is set to begin in January 2018. Additional cases over other testosterone drugs have also been scheduled for trial, with two trials against Auxulium Pharmaceuticals, the makers of Testim, set to begin in early November 2017 and April 2018. Two other cases against Eli Lilly, the makers of Axiron, are expected to go before juries in early 2018. While the outcomes of these early trial dates are not binding on plaintiffs not involved in the case, they are designed to help the parties test the relative strengths and weaknesses of their arguments and promote possible testosterone settlement agreements, which may avoid the need for each individual case to be remanded back to U.S. District Courts nationwide for separate trial dates in the future. Tags: AbbVie, AndroGel, Heart Attack, Testosterone, Testosterone Gel More Testosterone Lawsuit Stories Link Between Testosterone Drugs and Heart Risks Not Found in New Study June 19, 2023 Study’s Findings Question Link Between Testosterone Drugs and Blood Clots October 26, 2021 New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (Posted: yesterday) A federal judge has selected a Bard PowerPort infection lawsuit to serve as the first in a series of bellwether trials over claims the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCook Medical Angiographic Catheter Recall Issued Following Multiple Reports of Serious Injury: FDA (06/27/2025)More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts (06/03/2025)6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (05/19/2025) Status of Hair Dye Bladder Cancer Lawsuits Outlined for Court (Posted: 2 days ago) One hair dye bladder cancer lawsuit out of at least 15 filed to date has been chosen as the lead case against several cosmetics manufacturers. MORE ABOUT: HAIR DYE LAWSUIT12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (07/01/2025)Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025) Social Media Addiction Lawsuit Set for Trial in California State Court in November 2025 (Posted: 2 days ago) A series of social media addiction lawsuit trials will begin this November in California state court, as federal bellwether cases are prepared for likely 2026 trial dates. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITSnapchat Lawsuit Claims Platform Unleashed Experimental AI on Children Without Safeguards (07/09/2025)Fortnite Settlement Provides $126M in Payouts to Players Targeted With Unwanted Items: FTC (07/01/2025)Video Game Addiction Can Begin as Early as Elementary School: Study (06/27/2025)
New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020
Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (Posted: yesterday) A federal judge has selected a Bard PowerPort infection lawsuit to serve as the first in a series of bellwether trials over claims the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCook Medical Angiographic Catheter Recall Issued Following Multiple Reports of Serious Injury: FDA (06/27/2025)More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts (06/03/2025)6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (05/19/2025)
Status of Hair Dye Bladder Cancer Lawsuits Outlined for Court (Posted: 2 days ago) One hair dye bladder cancer lawsuit out of at least 15 filed to date has been chosen as the lead case against several cosmetics manufacturers. MORE ABOUT: HAIR DYE LAWSUIT12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (07/01/2025)Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)
Social Media Addiction Lawsuit Set for Trial in California State Court in November 2025 (Posted: 2 days ago) A series of social media addiction lawsuit trials will begin this November in California state court, as federal bellwether cases are prepared for likely 2026 trial dates. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITSnapchat Lawsuit Claims Platform Unleashed Experimental AI on Children Without Safeguards (07/09/2025)Fortnite Settlement Provides $126M in Payouts to Players Targeted With Unwanted Items: FTC (07/01/2025)Video Game Addiction Can Begin as Early as Elementary School: Study (06/27/2025)